JamesM.LarnerMD
Radiation Oncology • Charlottesville, VAAssociate Professor of Medicine, University VA School of Medicine
Dr. Larner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-982-3262
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1986 - 1989
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1985 - 1986- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1983 - 1985
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1981 - 1983
Albany Medical CenterInternship, Internal Medicine, 1980 - 1981
University of Virginia School of MedicineClass of 1980
Certifications & Licensure
NY State Medical License 1985 - Present
VA State Medical License 1983 - 2026
TN State Medical License 1989 - 1994
PA State Medical License 1981 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2006-2013
- Join now to see all
Clinical Trials
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma Start of enrollment: 2009 Jun 01
- Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2011 Mar 01
- A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy.Jonathan Colen, Cam Nguyen, Seth W Liyanage, Eric Aliotta, Joe Chen
Medical Physics. 2024-09-01 - 2 citationsZEB1 promotes non-homologous end joining double-strand break repair.Thomas L Genetta, Joshua C Hurwitz, Evan A Clark, Benjamin T Herold, Shadi Khalil
Nucleic Acids Research. 2023-10-13 - 11 citationsTranscriptome-wide association study and eQTL colocalization identify potentially causal genes responsible for human bone mineral density GWAS associations.Basel Maher Al-Barghouthi, Will T Rosenow, Kang-Ping Du, Jinho Heo, Robert Maynard
Elife. 2022-11-23
Press Mentions
OncLive® to Host State of the Science Summit™ on Advanced Non-Small Cell Lung CancerJuly 31st, 2018
Grant Support
- IR Signaling Through Pp6, A Potential Molecular Target For RadiosensitizationNational Cancer Institute2010–2012
- Mechanisms Of Radiosensitization By 2-Methoxyestradiol In Prostate Cancer ModelsNational Cancer Institute2008–2012
- Small Animal Radiation Research Platform With Cone-Beam CT GuidanceNational Center For Research Resources2010
- Protocol Review &MonitoringNational Cancer Institute2006–2010
- The Role Of Irradiation/Atm Activated Protein Phosphatase1 In The Damage ResponseNational Institute Of Environmental Health Sciences2007–2008
- The Role Of Ir/Atm Activated PP1 In The Damage ResponseNational Institute Of Environmental Health Sciences2004–2006
- Radiation Induced Chromatin Changes In A Defined OriginNational Cancer Institute1997–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
